We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPT icon
3176
Sprout Social
SPT
$621M
$941 ﹤0.01%
45
+13
+41% +$276
ATRO icon
3177
Astronics
ATRO
$3.84B
$937 ﹤0.01%
34
– –
PWZ icon
3178
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.17B
$934 ﹤0.01%
40
– –
CMTG icon
3179
Claros Mortgage Trust
CMTG
$274M
$932 ﹤0.01%
327
+242
+285% +$649
DAWN
3180
DELISTED
Day One Biopharmaceuticals
DAWN
$923 ﹤0.01%
142
+138
+3,450% +$949
ARLO icon
3181
Arlo Technologies
ARLO
$1.65B
$916 ﹤0.01%
54
-24
-31% -$307
PPTY
3182
US Diversified Real Estate ETF
PPTY
$25.6M
$912 ﹤0.01%
+30
New +$902
AKR icon
3183
Acadia Realty Trust
AKR
$2.84B
$910 ﹤0.01%
49
-37
-43% -$717
VRDN icon
3184
Viridian Therapeutics
VRDN
$2.67B
$909 ﹤0.01%
+65
New +$882
ACAD icon
3185
Acadia Pharmaceuticals
ACAD
$5.03B
$906 ﹤0.01%
42
-65
-61% -$1.21K
DHAI
3186
DELISTED
DIH Holdings US
DHAI
$905 ﹤0.01%
148
– –
ERIC icon
3187
Ericsson
ERIC
$33.3B
$899 ﹤0.01%
106
-331
-76% -$2.72K
SNDX icon
3188
Syndax Pharmaceuticals
SNDX
$1.82B
$899 ﹤0.01%
96
-236
-71% -$2.6K
BXC icon
3189
BlueLinx
BXC
$706M
$893 ﹤0.01%
12
-19
-61% -$1.33K
KTF
3190
DWS Municipal Income Trust
KTF
$352M
$884 ﹤0.01%
100
– –
OLP
3191
One Liberty Properties
OLP
$527M
$883 ﹤0.01%
37
– –
RELY icon
3192
Remitly
RELY
$5.14B
$882 ﹤0.01%
47
+32
+213% +$666
KYMR icon
3193
Kymera Therapeutics
KYMR
$8.94B
$873 ﹤0.01%
20
-8
-29% -$275
LUNG icon
3194
Pulmonx
LUNG
$87.6M
$870 ﹤0.01%
336
– –
TH icon
3195
Target Hospitality
TH
$1.64B
$862 ﹤0.01%
121
+67
+124% +$465
FTGS icon
3196
First Trust Growth Strength ETF
FTGS
$1.35B
$857 ﹤0.01%
+25
New +$785
GTO icon
3197
Invesco Total Return Bond ETF
GTO
$2.47B
$844 ﹤0.01%
18
-1,156
-98% -$53.6K
BAND
3198
Bandwidth Inc
BAND
$1.61B
$843 ﹤0.01%
53
-17
-24% -$231
ORIC icon
3199
Oric Pharmaceuticals
ORIC
$1.4B
$842 ﹤0.01%
+83
New +$557
PD icon
3200
PagerDuty
PD
$902M
$840 ﹤0.01%
55
+35
+175% +$544
126 127
128
129 130

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.